US20230203538A1 - In vivo targeting of Fibrosis by anti-CD5

WO2015183842A1 - Methods and compositions for preventing ischemia

PHD1 regulates p53‐mediated colorectal cancer chemoresistance

HIF-1α regulates the expression of the non-conventional isoform of

The mechanism of how CD95/Fas activates the Type I IFN/STAT1 axis

Targeting activated hepatic stellate cells (aHSCs) for liver

Targeted hybrid nanovesicles for imaging pancreatic cancer

HELIOS Monoclonal Antibody (22F6), Brilliant Ultra Violet™ 563

Frontiers T Cells in Fibrosis and Fibrotic Diseases

News: Gene-Editing Clinical Trial Update - CRISPR Medicine